$SINT News

SINTX Technologies Regains Nasdaq Compliance

Sintx Technologies, Inc. (SINT) Q2 2026 Earnings Call Prepared Remarks Transcript

SINTX Technologies Q2 EPS $(0.75) Misses $(0.66) Estimate, Sales $452.000K Beat $406.667K Estimate

SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast

SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

SINTX Technologies Receives Purchase Orders From Multiple Contract Manufacturing Customers With Aggregate Value Exceeding $3.2M For Production Of Advanced Ceramic Components

Sintx Technologies Insiders Placed Bullish Bets Worth US$644.2k

Maxim Group Reinstates Buy on SINTX Technologies, Announces $6 Price Target

SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SINTX Technologies Announces $4.5M Private Placement, Issuing 1,882,845 Shares At $2.39 Combined Price With Warrants For 1,882,845 Class A And 1,882,845 Class B Shares Exercisable At $2.14

Why SINTX Technologies Stock Is Trading Lower Today

Sintx Technologies Receives Nasdaq Noncompliance Notice, Gets Time Through July 6 To Regain Compliance

HC Wainwright & Co. Reiterates Buy on SINTX Technologies, Maintains $10 Price Target

SINTX Technologies to Present at the LD Micro Invitational XVI Conference

SINTX Technologies Q1 EPS $(0.70) Misses $(0.66) Estimate, Sales $380.000K Beat $300.000K Estimate

HC Wainwright & Co. Initiates Coverage On SINTX Technologies with Buy Rating, Announces Price Target of $10

Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $12

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

SINTX Releases Corporate Update On Key Milestones, Including First Human Surgical Procedure Using FDA-Approved Foot & Ankle Osteotomy Wedge System